Current Report Filing (8-k)
June 03 2020 - 4:16PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): June 3, 2020
NanoVibronix,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State
or other jurisdiction of incorporation)
001-36445
|
|
01-0801232
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
525
Executive Blvd., Elmsford, NY 10523
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (914) 233-3004
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.001 per share
|
|
NAOV
|
|
Nasdaq
Capital Market
|
Item
5.08 Shareholder Director Nominations
On
June 3, 2020, the board of directors (the “Board”) of NanoVibronix, Inc. (the “Company”) established
August 11, 2020, as the date for the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) and
set June 12, 2020, as the record date for the Annual Meeting. Due to the fact that the date of the Annual Meeting has been changed
by more than 30 days from the anniversary date of the 2019 Annual Meeting of Stockholders, the Company is providing the due date
for submission of any qualified stockholder proposal or qualified stockholder nominations.
In
accordance with Rule 14a-5(f) and Rule 14a-8(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the Company’s amended and restated bylaws, the deadline for receipt of stockholder proposals or nominations for inclusion
in the Company’s proxy statement for the Annual Meeting pursuant to Rule 14a-8 will be no later than 5:00 p.m., Eastern
Time, June 13, 2020. Stockholder proposals must comply with all of the applicable requirements set forth in the rules and regulations
of the Securities and Exchange Commission, including Rule 14a-8 under the Exchange Act and the Company’s amended and restated
bylaws.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
NANOVIBRONIX,
INC.
|
|
|
|
Date:
June 3, 2020
|
By:
|
/s/
Brian Murphy
|
|
Name:
|
Brian
Murphy
|
|
Title:
|
Chief
Executive Officer
|
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jul 2023 to Jul 2024